238 related articles for article (PubMed ID: 24417420)
41. Xeroderma pigmentosum: heterogeneous syndrome and model for UV carcinogenesis.
Jung EG
Bull Cancer; 1978; 65(3):315-21. PubMed ID: 719183
[TBL] [Abstract][Full Text] [Related]
42. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
43. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum.
Sollitto RB; Kraemer KH; DiGiovanna JJ
J Am Acad Dermatol; 1997 Dec; 37(6):942-7. PubMed ID: 9418761
[TBL] [Abstract][Full Text] [Related]
44. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
45. In vivo assessment of acute UVB responses in normal and Xeroderma Pigmentosum (XP-C) skin-humanized mouse models.
García M; Llames S; García E; Meana A; Cuadrado N; Recasens M; Puig S; Nagore E; Illera N; Jorcano JL; Del Rio M; Larcher F
Am J Pathol; 2010 Aug; 177(2):865-72. PubMed ID: 20558577
[TBL] [Abstract][Full Text] [Related]
46. [Light protection for xeroderma pigmentosum].
Ettinger M; Berneburg M
Hautarzt; 2017 May; 68(5):359-363. PubMed ID: 28401271
[TBL] [Abstract][Full Text] [Related]
47. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
48. Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew.
Christen-Zaech S; Imoto K; Khan SG; Oh KS; Tamura D; Digiovanna JJ; Boyle J; Patronas NJ; Schiffmann R; Kraemer KH; Paller AS
Arch Dermatol; 2009 Nov; 145(11):1285-91. PubMed ID: 19917958
[TBL] [Abstract][Full Text] [Related]
49. Xeroderma pigmentosum in the United kingdom.
Lehmann AR
Photochem Photobiol; 2015; 91(2):484-5. PubMed ID: 24943090
[TBL] [Abstract][Full Text] [Related]
50. Xeroderma pigmentosum variant with multisystem involvement.
Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
[TBL] [Abstract][Full Text] [Related]
51. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
Sugasawa K
Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
[TBL] [Abstract][Full Text] [Related]
52. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
[TBL] [Abstract][Full Text] [Related]
53. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
[TBL] [Abstract][Full Text] [Related]
54. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
55. Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription.
van Hoffen A; Kalle WH; de Jong-Versteeg A; Lehmann AR; van Zeeland AA; Mullenders LH
Nucleic Acids Res; 1999 Jul; 27(14):2898-904. PubMed ID: 10390531
[TBL] [Abstract][Full Text] [Related]
56. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study.
Bhutto AM; Shaikh A; Nonaka S
Br J Dermatol; 2005 Mar; 152(3):545-51. PubMed ID: 15787826
[TBL] [Abstract][Full Text] [Related]
57. Novel therapeutic approaches to xeroderma pigmentosum.
Weon JL; Glass DA
Br J Dermatol; 2019 Aug; 181(2):249-255. PubMed ID: 30265743
[TBL] [Abstract][Full Text] [Related]
58. Reduced levels of UV-induced unscheduled DNA synthesis in epidermal keratinocytes of patients with xeroderma pigmentosum and correlation with development of skin neoplasms.
Kondo S; Satoh Y; Kuroki T
Cancer Res; 1989 Apr; 49(8):1927-30. PubMed ID: 2467739
[TBL] [Abstract][Full Text] [Related]
59. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
60. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
